Diagnostic serum markers are also in high demand for the early detection of lung cancer, and two strong biomarker candidates, cytoskeleton-associated protein 4 (CKAP4) and calnexin (CANX), have been identified using RPPAs (104, 105). This evidence concerns the gene CANX and lung carcinoma.